on 19 Jun 2024
Last Applicant/ Owned by
Nxera Pharma UK Limited
Granta Park , Great Abington, Cambridge , Cambridgeshire
, , CB21 6DG
Serial Number
UK00004065667 filed on 19th Jun 2024
Registration Number
UK00004065667 registered on
20th Sept 2024
Correspondent Information
Gill Jennings & Every LLP
The Broadgate Tower, 20 Primrose Street
London,
EC2A 2ES
Databases; database server software; computer database servers; interactive databases; database management software; computer databases; electronic databases; Software for use in relation to bio-technology, pharmaceutical, chemical and medical testing and development; software for use in the pharmaceutical and biopharmaceutical fields, including technologies related to proteins and G-protein-coupled receptors drug and pharmaceutical discovery services; software for target identification in relation to developing pharmaceuticals.
Database design; development of databases; maintaining databases; consultancy of computer database software; database development services; installation, maintenance and updating of database software; scientific research conducted using databases; providing scientific research information and results from an online searchable database; Platform as a Service [PaaS]; drug and pharmaceutical discovery services; bio-technology, pharmaceutical, chemical and medical testing, research, development, advice, consultancy and information services; research and development services in the pharmaceutical and biopharmaceutical fields, including technologies related to proteins and G-protein-coupled receptors; pharmaceutical research services in chemical and biological drug discovery and development; research and development services for identifying lead chemical compounds; examination and research services in medicinal and synthetic chemistry; research and development services in the creation of libraries or collections of biologicals, chemicals and compounds; research, creation, development and provision of chemical and biological drug targets for screening purposes; research, analysis and examination for identification of compounds through automated screening processes; research and development services in chemical and biological pharmaceutical development; medical laboratory services; provision of information, advisory services and consultancy relating to the aforesaid services; software platforms for use in relation to bio-technology, pharmaceutical, chemical and medical testing and development; software platforms for use in the pharmaceutical and biopharmaceutical fields, including technologies related to proteins and G-protein-coupled receptors drug and pharmaceutical discovery services; software platforms for target identification in relation to developing pharmaceuticals.
Pharmaceutical services; medical services; pharmaceutical advice and consultancy for medical purposes; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; research, creation, development and provision of chemical and biological drug targets for medical screening purposes; medical services relating to identification and validation of drug targets; medical services relating to design and development of medicines; medical and pharmaceutical services being X-ray crystallography and cryo-electron microscopy; all of the aforesaid relating to drug discovery and use of G-protein- coupled receptors in the design and development of pharmaceutical products.
UK00004065667
Word
Individual